110 Countries Benefit From Medicines Patent Pool/BMS Deal On Atazanavir
This article was originally published in The Pink Sheet Daily
Executive Summary
The Medicines Patent Pool’s deal with BMS for licenses for the manufacture and supply of atazanavir for low- to middle-income countries will benefit up to a million HIV sufferers.